{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:34:18Z","timestamp":1793928858637,"version":"4.8.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaccao.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:09:19Z","timestamp":1724177359000},"page":"475-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cardiovascular Disease After Hematopoietic Stem Cell Transplantation\u00a0in Adults"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-913X","authenticated-orcid":false,"given":"David G.","family":"Gent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2024.06.004_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jaccao.2024.06.004_bib4","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","article-title":"Hematopoietic-cell transplantation at 50","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/jamaoncol.2021.3676","article-title":"Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report","volume":"7","author":"Bhatia","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib7","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1200\/JCO.21.02372","article-title":"Trends in late mortality and life expectancy after autologous blood or marrow transplantation over three decades: a BMTSS report","volume":"40","author":"Bhatia","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7861\/clinmedicine.18-4-329","article-title":"Autologous haematopoietic stem cell transplantation (aHCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist","volume":"18","author":"Snowden","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jaccao.2024.06.004_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.2015.141119","article-title":"How to select the best available related or unrelated donor of hematopoietic stem cells?","volume":"101","author":"Tiercy","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jaccao.2024.06.004_bib10","doi-asserted-by":"crossref","first-page":"909.e1","DOI":"10.1016\/j.jtct.2021.08.013","article-title":"Nonmyeloablative, HLA-mismatched unrelated peripheral blood transplantation with high-dose post-transplantation cyclophosphamide","volume":"27","author":"Rappazzo","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.exphem.2016.04.005","article-title":"Peripheral blood stem cell versus bone marrow transplantation: a perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"44","author":"Byrne","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib13","first-page":"Cd010189","article-title":"Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults","volume":"2014","author":"Holtick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaccao.2024.06.004_bib14","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.06.004_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2014.10.011","article-title":"Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?","volume":"21","author":"Hurley","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib19","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.06.004_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaccao.2020.06.011","article-title":"Left ventricular systolic function in long-term survivors of allogeneic hematopoietic stem cell transplantation","volume":"2","author":"Massey","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ejh.13482","article-title":"Clinical prevalence and outcome of cardiovascular events in the first 100\u00a0days postallogeneic hematopoietic stem cell transplant","volume":"106","author":"Alblooshi","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib22","first-page":"1","article-title":"Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival","volume":"9","author":"Auberle","year":"2023","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2024.06.004_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clml.2019.12.027","article-title":"Cardiotoxicity in hematopoietic stem cell transplant: keeping the beat","volume":"20","author":"Baker","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaccao.2024.06.004_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.20.02401","article-title":"Atrial fibrillation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"39","author":"Chang","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dul\u00e9ry","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.30534","article-title":"Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002007","article-title":"Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation","volume":"9","author":"Moriyama","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.jaccao.2024.06.004_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaccao.2023.07.007","article-title":"Cardiovascular events after hematopoietic stem cell transplant: incidence and risk factors","volume":"5","author":"Vasbinder","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib29","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1182\/bloodadvances.2021004846","article-title":"Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era","volume":"5","author":"Yeh","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaccao.2024.06.004_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s002770000186","article-title":"Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure","volume":"79","author":"Zenh\u00e4usern","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000227267","article-title":"Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature","volume":"122","author":"Ruiz-Delgado","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2003-07-2345","article-title":"Cardiac toxicity of alemtuzumab in patients with mycosis fungoides\/S\u00e9zary syndrome","volume":"104","author":"Lenihan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/WNL.0000000000005417","article-title":"Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis","volume":"90","author":"Ferraro","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jaccao.2024.06.004_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/annonc\/mdh114","article-title":"Coronary ischemia related to alemtuzumab therapy","volume":"15","author":"Basquiera","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jccase.2014.07.004","article-title":"Alemtuzumab induced ST-segment elevation and acute myocardial dysfunction","volume":"10","author":"Attarian","year":"2014","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jaccao.2024.06.004_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/1352458519855725","article-title":"Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclerosis","volume":"26","author":"Ahrabian","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaccao.2024.06.004_bib37","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","article-title":"Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"45","author":"Peres","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1704487","article-title":"Predictors for severe cardiac complications after hematopoietic stem cell transplantation","volume":"33","author":"Sakata-Yanagimoto","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib40","article-title":"Cardiovascular risk stratification of patients undergoing hematopoietic stem cell transplantation: the CARE-BMT risk score","volume":"13","author":"Vasbinder","year":"2024","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2024.06.004_bib41","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.2353\/ajpath.2010.090690","article-title":"Cardiotoxicity of the anticancer therapeutic agent bortezomib","volume":"176","author":"Nowis","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejim.2022.09.016","article-title":"Ibrutinib use and adverse cardiovascular outcomes: a United States federated electronic medical records analysis","volume":"108","author":"Gent","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib43","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-mediated atrial fibrillation attributable to inhibition of c-terminal Src kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.06.004_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0609.2002.01661.x","article-title":"Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide","volume":"69","author":"Auner","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.1991.9.7.1215","article-title":"Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens","volume":"9","author":"Braverman","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib46","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","article-title":"Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations","volume":"57","author":"Cazin","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib47","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","article-title":"Cardiotoxicity associated with high-dose cyclophosphamide therapy","volume":"141","author":"Gottdiener","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","article-title":"The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HCT)","volume":"95","author":"Ishida","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib49","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1200\/JCO.2017.72.6869","volume":"35","author":"Mart\u00ednez","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbmt.2015.09.002","volume":"22","author":"Bashey","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","article-title":"Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors","volume":"25","author":"Brockstein","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib53","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bmt.2017.188","article-title":"Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening","volume":"52","author":"Martin","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2350\/13-04-1324-CR.1","article-title":"Cyclophosphamide-associated cardiotoxicity in a child after stem cell transplantation for \u03b2-thalassemia major: case report and review of the literature","volume":"17","author":"Meserve","year":"2014","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib55","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J\u00a0Investig Med High Impact Case Rep"},{"key":"10.1016\/j.jaccao.2024.06.004_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1083-8791(00)70043-7","article-title":"Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer","volume":"6","author":"Nieto","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131394","article-title":"Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention","volume":"10","author":"Nishikawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaccao.2024.06.004_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1095-6433(98)10135-6","article-title":"In\u00a0vivo prevention of cyclophosphamide-induced Ca2+ dependent damage of rat heart and liver mitochondria by cyclosporin A","volume":"121","author":"al-Nasser","year":"1998","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4161\/oxim.3.5.13107","article-title":"Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues","volume":"3","author":"Asiri","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jaccao.2024.06.004_bib60","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.06.004_bib61","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/1097-0142(19911101)68:9<1910::AID-CNCR2820680911>3.0.CO;2-E","article-title":"Myocardial ischemia associated with high-dose carmustine infusion","volume":"68","author":"Kanj","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1703632","article-title":"Acute myocardial ischemia after high-dose therapy with BEAM regimen","volume":"30","author":"Genet","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib63","article-title":"Cytarabine-induced bradycardia: a case report","volume":"14","author":"Albsheer","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jaccao.2024.06.004_bib64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/10428190701332456","article-title":"Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report","volume":"48","author":"Cil","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaccao.2024.06.004_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jccase.2013.06.002","article-title":"Low-dose cytosine arabinoside-induced symptomatic bradycardia in a patient with acute myeloid leukemia","volume":"8","author":"Erdem","year":"2013","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jaccao.2024.06.004_bib66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2354.2008.00953.x","article-title":"Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution","volume":"18","author":"Romani","year":"2009","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jaccao.2024.06.004_bib67","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2459\/JCM.0b013e328341d0e5","article-title":"High-dose cytosine arabinoside-induced symptomatic bradycardia","volume":"16","author":"Wayangankar","year":"2015","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jaccao.2024.06.004_bib68","first-page":"348","article-title":"Acute pericarditis and pleural effusion complicating cytarabine chemotherapy","volume":"26","author":"G\u00e4hler","year":"2003","journal-title":"Onkologie"},{"key":"10.1016\/j.jaccao.2024.06.004_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002770050312","article-title":"Pericarditis induced by high-dose cytosine arabinoside chemotherapy","volume":"75","author":"Hermans","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0145-2126(94)00123-R","article-title":"Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy","volume":"19","author":"Reykdal","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaccao.2024.06.004_bib71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0145-2126(98)00008-3","article-title":"Evidence for sinoatrial blockade associated with high dose cytarabine therapy","volume":"22","author":"Stamatopoulos","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaccao.2024.06.004_bib72","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/archinte.1984.00350210198035","article-title":"Pericarditis induced by high-dose cytarabine therapy","volume":"144","author":"Vaickus","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib73","first-page":"723","article-title":"Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer","volume":"52","author":"Shoji","year":"2006","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.jaccao.2024.06.004_bib74","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/j.jccase.2013.02.009","article-title":"Two cases of acute myocardial infarction during combined chemotherapy in young patients with testicular cancer","volume":"7","author":"Kawano","year":"2013","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jaccao.2024.06.004_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jccase.2019.05.001","article-title":"Persistent heart failure following melphalan and fludarabine conditioning","volume":"20","author":"Newbery","year":"2019","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jaccao.2024.06.004_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","article-title":"Acute left ventricular failure following melphalan and fludarabine conditioning","volume":"28","author":"Ritchie","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2014.926346","article-title":"Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma","volume":"56","author":"Gul","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaccao.2024.06.004_bib78","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2141.2001.03153.x","article-title":"Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study","volume":"115","author":"Martino","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib79","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1701217","article-title":"Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells","volume":"21","author":"Olivieri","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2004.03.001","article-title":"Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study","volume":"10","author":"Phillips","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1704166","article-title":"Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies","volume":"32","author":"Van Besien","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib82","first-page":"4","article-title":"A\u00a0case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest","volume":"6","author":"Ma","year":"2020","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2024.06.004_bib83","article-title":"Melphalan-induced cardiotoxicity: ventricular arrhythmias","volume":"2016","author":"Yanamandra","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaccao.2024.06.004_bib84","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1083-8791(99)70008-X","article-title":"Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors","volume":"5","author":"Alidina","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib85","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/rheumatology\/ket464","article-title":"Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations","volume":"53","author":"Henes","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaccao.2024.06.004_bib86","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2017.12.785","article-title":"Transplant conditioning with treosulfan\/fludarabine with or without total body irradiation: a randomized phase II trial in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"24","author":"Deeg","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbmt.2014.01.009","article-title":"Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"20","author":"Gyurkocza","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib88","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbmt.2016.12.623","article-title":"Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis","volume":"23","author":"Friedman","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib90","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study","volume":"169","author":"Meacham","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib91","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1210\/jc.2006-0128","article-title":"Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors","volume":"91","author":"Neville","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaccao.2024.06.004_bib92","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/blood-2010-09-304899","article-title":"Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia","volume":"117","author":"Oudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib93","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","article-title":"Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL)","volume":"69","author":"Steffens","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaccao.2024.06.004_bib94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1705023","article-title":"Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients","volume":"36","author":"Rhodes","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib96","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11239-020-02344-9","article-title":"Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation","volume":"51","author":"Rotz","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jaccao.2024.06.004_bib97","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ecl.2007.07.002","article-title":"Endocrine complications of hematopoietic stem cell transplantation","volume":"36","author":"Chemaitilly","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaccao.2024.06.004_bib98","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(12)70323-6","article-title":"Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study","volume":"13","author":"de Vathaire","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00043426-200402000-00003","article-title":"Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation","volume":"26","author":"Hoffmeister","year":"2004","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib100","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0025-6196(12)65772-3","article-title":"Cyclosporine-induced hypertension after transplantation","volume":"69","author":"Textor","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaccao.2024.06.004_bib101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib102","first-page":"269","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib103","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib104","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bmt.1703890","article-title":"Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue","volume":"31","author":"Akahori","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-9966-31-13","article-title":"Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Roziakova","year":"2012","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jaccao.2024.06.004_bib106","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bjh.13357","article-title":"Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation","volume":"169","author":"Liu","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bmt.1701609","article-title":"Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases","volume":"23","author":"Alessandrino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1753944712464102","article-title":"Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors","volume":"6","author":"Sureddi","year":"2012","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jaccao.2024.06.004_bib109","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2013.05.019","article-title":"Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation","volume":"19","author":"Singla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bmt.1704623","article-title":"Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"34","author":"Hidalgo","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.20042","article-title":"Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation","volume":"76","author":"Nakamae","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib112","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.transproceed.2007.11.077","article-title":"Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity","volume":"40","author":"Sucak","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaccao.2024.06.004_bib113","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","article-title":"Arrhythmias in the setting of hematopoietic cell transplants","volume":"50","author":"Tonorezos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib114","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ijcard.2012.06.021","article-title":"Heart failure after allogeneic hematopoietic stem cell transplantation","volume":"167","author":"Mo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.bmt.1704610","article-title":"Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?","volume":"34","author":"Tang","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib116","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bmt.2012.253","article-title":"Factors affecting the development of atrial fibrillation and atrial flutter (AF\/AFL) following autologous hematopoietic SCT (auto-HCT)","volume":"48","author":"Steuter","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib117","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1200\/JCO.1998.16.12.3796","article-title":"Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients","volume":"16","author":"Goldberg","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib118","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ejh.13322","article-title":"Arrhythmias in hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"103","author":"Chiengthong","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20904","article-title":"Melphalan-induced supraventricular tachycardia: incidence and risk factors","volume":"34","author":"Feliz","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbmt.2010.12.698","article-title":"Retrospective outcome data for hematopoietic stem cell transplantation in patients with concurrent coronary artery disease","volume":"17","author":"Stillwell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib121","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.12516","article-title":"Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation","volume":"163","author":"Armenian","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib123","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1200\/JCO.2008.17.7428","article-title":"Late congestive heart failure after hematopoietic cell transplantation","volume":"26","author":"Armenian","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib124","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbmt.2010.02.021","article-title":"Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation","volume":"16","author":"Armenian","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib125","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","article-title":"Prediction of cardiovascular disease among hematopoietic cell transplantation survivors","volume":"2","author":"Armenian","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaccao.2024.06.004_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","article-title":"Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation","volume":"155","author":"Chow","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib127","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib128","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2016.02.017","article-title":"Clinical and genetic determinants of cardiomyopathy risk among hematopoietic cell transplantation survivors","volume":"22","author":"Leger","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.bmt.1702466","article-title":"Cardiac systolic function before and after hematopoietic stem cell transplantation","volume":"26","author":"Lehmann","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib130","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib131","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2015.60.8125","article-title":"Heart failure and asymptomatic left ventricular systolic dysfunction in lymphoma survivors treated with autologous stem-cell transplantation: a national cross-sectional study","volume":"33","author":"Murbraech","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib132","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2009.06.001","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction","volume":"15","author":"Qazilbash","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib133","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib134","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u2018novel\u2019 target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib136","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/10428190500235884","article-title":"Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older","volume":"46","author":"Mileshkin","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaccao.2024.06.004_bib137","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajh.21459","article-title":"Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation","volume":"84","author":"Fatema","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib138","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/hrt.2007.123299","article-title":"Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function","volume":"94","author":"Chung","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jaccao.2024.06.004_bib139","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib140","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41409-023-01928-2","article-title":"Cardiovascular events among recipients of hematopoietic stem cell transplantation-a systematic review and meta-analysis","volume":"58","author":"Aghel","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib141","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2796.1990.tb00155.x","article-title":"Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance","volume":"227","author":"Kupari","year":"1990","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib142","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jaccao.2024.06.004_bib143","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033490","article-title":"Role of endothelial cells in graft-versus-host disease","volume":"13","author":"Neidemire-Colley","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.currproblcancer.2018.05.008","article-title":"Cardiovascular effects of radiation therapy","volume":"42","author":"Armanious","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib146","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/blood-2010-03-276576","article-title":"Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management","volume":"116","author":"Griffith","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.981838","article-title":"Cardiovascular effects of immunosuppression agents","volume":"9","author":"Elezaby","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline Chemotherapy and Cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib150","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib151","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib152","series-title":"Critical Care of the Pediatric Immunocompromised Hematology\/Oncology Patient: An Evidence-Based Guide","first-page":"211","article-title":"Cardiac dysfunction in hematology oncology and hematopoietic cell transplant patients","author":"Ghafoor","year":"2019"},{"key":"10.1016\/j.jaccao.2024.06.004_bib153","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2017.08.035","volume":"24","author":"Ovchinsky","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib154","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hemonc.2017.05.009","article-title":"Long-term complications after hematopoietic cell transplantation","volume":"10","author":"Majhail","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib156","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/bmt.2017.190","article-title":"Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany","volume":"52","author":"Kuba","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib157","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1182\/blood-2011-04-348730","article-title":"Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS)","volume":"118","author":"Sun","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib158","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.06.004_bib159","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaccao.2021.11.008","article-title":"Cardiovascular disease among patients with AML and CHIP-related mutations","volume":"4","author":"Calvillo-Arg\u00fcelles","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib160","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis","volume":"3","author":"Carobbio","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaccao.2024.06.004_bib161","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib162","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2024.06.004_bib163","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jamacardio.2023.4105","article-title":"Clonal hematopoiesis and cardiovascular disease in patients with multiple myeloma undergoing hematopoietic cell transplant","volume":"9","author":"Rhee","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib164","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.21.02286","article-title":"Donor clonal hematopoiesis and recipient outcomes after transplantation","volume":"40","author":"Gibson","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1475-097X.2009.00920.x","article-title":"Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphoma","volume":"30","author":"Kuittinen","year":"2010","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.jaccao.2024.06.004_bib166","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","article-title":"QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide","volume":"355","author":"Nakamae","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2024.06.004_bib167","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1702507","article-title":"Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide","volume":"26","author":"Snowden","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib168","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10245330600774991","article-title":"Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation","volume":"11","author":"Takatsuka","year":"2006","journal-title":"Hematology"},{"key":"10.1016\/j.jaccao.2024.06.004_bib169","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaccao.2020.08.014","article-title":"Cardiac biomarkers during cancer therapy: practical applications for cardio-oncology","volume":"2","author":"Alvarez-Cardona","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.jaccao.2024.06.004_bib170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11864-021-00850-3","article-title":"Cardiovascular issues in hematopoietic stem cell transplantation (HCT)","volume":"22","author":"L\u00f3pez-Fern\u00e1ndez","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib171","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/jha2.599","article-title":"Cardiovascular screening prior to stem cell transplantation in the United Kingdom","volume":"3","author":"Gent","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.jaccao.2024.06.004_bib172","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib173","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2011.40.3584","article-title":"Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and magnetic resonance imaging","volume":"30","author":"Armstrong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib174","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaccao.2020.10.011","article-title":"Strain imaging in cardio-oncology","volume":"2","author":"Liu","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.echo.2017.08.017","article-title":"Prognostic and added value of two-dimensional global longitudinal strain for prediction of survival in patients with light chain amyloidosis undergoing autologous hematopoietic cell transplantation","volume":"31","author":"Pun","year":"2018","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2024.06.004_bib176","first-page":"173","article-title":"Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib177","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","article-title":"Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant","volume":"12","author":"Hertenstein","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib178","first-page":"561","article-title":"Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group","volume":"17","author":"Jain","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib179","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1701734","article-title":"Predictive value of left ventricular ejection fraction in stem cell transplantation","volume":"23","author":"Zangari","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib180","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1456","article-title":"Variability in ejection fraction measured by echocardiography, gated single-photon emission computed tomography, and cardiac magnetic resonance in patients with coronary artery disease and left ventricular dysfunction","volume":"1","author":"Pellikka","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaccao.2024.06.004_bib181","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/hrt.2007.121558","article-title":"Cardiopulmonary exercise testing and its application","volume":"83","author":"Albouaini","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaccao.2024.06.004_bib182","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/bmt.2014.159","article-title":"Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study","volume":"49","author":"Kelsey","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib183","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clml.2014.09.002","article-title":"Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study","volume":"15","author":"Tuchman","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jaccao.2024.06.004_bib184","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/bmt.2013.58","article-title":"Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study","volume":"48","author":"Wood","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaccao.2024.06.004_bib185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaccao.2021.01.008","article-title":"Role of physical activity and cardiac rehabilitation in patients undergoing hematopoietic stem cell transplantation","volume":"3","author":"Mohananey","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib186","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.2019003893","article-title":"How I treat cardiovascular complications in patients with lymphoid malignancies","volume":"139","author":"Herrmann","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib187","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/bjc.2016.180","article-title":"Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation","volume":"115","author":"Stenehjem","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib188","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2024.06.004_bib189","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaccao.2023.03.013","article-title":"Prediction of coronary heart disease events in blood or marrow transplantation recipients","volume":"5","author":"Gangaraju","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib190","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"Bosch","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib191","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.critrevonc.2015.11.007","article-title":"Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training","volume":"98","author":"Scott","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib192","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jnci\/djy231","article-title":"Impact of sarcopenia on adverse outcomes after allogeneic hematopoietic cell transplantation","volume":"111","author":"Armenian","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2024.06.004_bib193","doi-asserted-by":"crossref","first-page":"263.e261","DOI":"10.1016\/j.jtct.2023.01.015","article-title":"Sarcopenia predicts inferior progression-free survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation","volume":"29","author":"Sumransub","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jaccao.2024.06.004_bib194","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.1161\/CIR.0000000000001220","article-title":"Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from pretransplantation to survivorship: a scientific statement from the American Heart Association","volume":"149","author":"Hayek","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.06.004_bib195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.06.004_bib196","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.06.004_bib197","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib198","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.06.004_bib199","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/CIRCULATIONAHA.123.064274","article-title":"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I\u2013guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial","volume":"148","author":"Henriksen","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.06.004_bib200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jaccao.2024.06.004_bib201","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaccao.2021.05.005","article-title":"How to perform pericardiocentesis in cancer patients with thrombocytopenia","volume":"3","author":"Jacob","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib202","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S1470-2045(23)00012-8","article-title":"Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"24","author":"Ehrhardt","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2024.06.004_bib203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2021.06.021","article-title":"Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"156","author":"van Dalen","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaccao.2024.06.004_bib204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:22:50Z","timestamp":1734567770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087324002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":204,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2666087324002254"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.06.004","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disease After Hematopoietic Stem Cell Transplantation\u00a0in Adults","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}